Kubota Pharmaceutical Holdings Co., Ltd.
4596 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 千代田区霞が関３丁目７番１号
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Kubota Pharmaceutical Holdings Co., Ltd. is a pioneering Japanese company dedicated to the mission of curing blindness. Through its subsidiary, Kubota Vision Inc., the company focuses on developing innovative drugs and devices aimed at preserving and restoring vision for millions globally. With a commitment to transforming cutting-edge research into practical solutions, Kubota Pharmaceutical is at the forefront of advancements in ocular health. The company envisions a world without blindness, striving to make significant contributions to the field of ophthalmology. By leveraging a diverse portfolio of therapeutic options, Kubota aims to enhance the quality of life for individuals affected by vision impairment, solidifying its role as a leader in the pharmaceutical industry.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-16 08:30 |
Inside Information Statement
臨時報告書
|
Japanese | 40.1 KB | |
| 2025-06-30 08:37 |
Regulatory News Service
訂正臨時報告書
|
Japanese | 28.6 KB | |
| 2025-06-20 08:30 |
Inside Information Statement
臨時報告書
|
Japanese | 27.5 KB | |
| 2025-04-21 08:30 |
Inside Information Statement
臨時報告書
|
Japanese | 23.8 KB | |
| 2025-03-28 08:10 |
Regulatory News Service
確認書
|
Japanese | 8.4 KB | |
| 2025-03-28 08:09 |
Annual Report
有価証券報告書－第10期(2024/01/01－2024/12/31)
|
Japanese | 945.2 KB | |
| 2025-03-28 08:09 |
Internal Control over Financial Reporting
内部統制報告書－第10期(2024/01/01－2024/12/31)
|
Japanese | 22.6 KB | |
| 2024-08-20 08:11 |
Prospectus
有価証券届出書（組込方式）
|
Japanese | 231.3 KB | |
| 2024-08-14 08:03 |
Regulatory News Service
確認書
|
Japanese | 8.5 KB | |
| 2024-08-14 08:02 |
Interim Report
半期報告書－第10期(2024/01/01－2024/12/31)
|
Japanese | 208.9 KB | |
| 2024-05-14 08:01 |
Regulatory News Service
確認書
|
Japanese | 8.3 KB | |
| 2024-05-14 08:00 |
Quarterly Report
四半期報告書－第10期第1四半期(2024/01/01－2024/03/31)
|
Japanese | 190.7 KB | |
| 2024-04-22 08:00 |
Inside Information Statement
臨時報告書
|
Japanese | 23.7 KB | |
| 2024-03-29 07:55 |
Internal Control over Financial Reporting
内部統制報告書－第9期(2023/01/01－2023/12/31)
|
Japanese | 22.6 KB | |
| 2024-03-29 07:54 |
Regulatory News Service
確認書
|
Japanese | 8.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
iDNA Genomics Public Ltd | Cyprus | IDNA | |
|
Idorsia Ltd | Switzerland | IDIA | |
|
ILIKA PLC | United Kingdom | IGE | |
|
Immuno-Biological Laboratories Co., Ltd. | Japan | 4570 | |
|
Indivior PLC | United Kingdom | INDV | |
|
Infant Bacterial Therapeutics | Sweden | IBT | |
|
Initiator Pharma A/S | Denmark | INIT | |
|
Intercure Ltd. | Israel | INCR | |
|
Intervacc AB | Sweden | IVACC | |
|
Ipsen | France | IPN |